Tech Company Financing Transactions

InventisBio Funding Round

InventisBio closed a $147 million Series D funding round on 9/30/2020. Investors included GL Ventures, Advantech and AIHC Capital.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series D
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Mailing Address
1000 Zhangheng Rd. Building 63 Pudong New District
Shanghai, 201203
Email Address
InventisBio is a dynamic and fast-growing global biotech company with multiple therapeutic agents at clinical stage. InventisBio focuses on discovery and development of novel therapeutics in the areas of oncology and metabolic diseases to address unmet medical needs.
InventisBio LinkedIn Company Profile
Social Media
InventisBio Company Twitter Account
Company News
InventisBio News
InventisBio on Facebook
InventisBio on YouTube

Management Team

Email & Social
Chief Executive Officer
Yaolin Wang
  Yaolin Wang LinkedIn Profile  Yaolin Wang Twitter Account  Yaolin Wang News  Yaolin Wang on Facebook
Chief Medical Officer
Ling Zhang
  Ling Zhang LinkedIn Profile  Ling Zhang Twitter Account  Ling Zhang News  Ling Zhang on Facebook
VP - R & D
David Dai
  David Dai LinkedIn Profile  David Dai Twitter Account  David Dai News  David Dai on Facebook
VP - R & D
Jack Jiang
  Jack Jiang LinkedIn Profile  Jack Jiang Twitter Account  Jack Jiang News  Jack Jiang on Facebook



Browse more venture capital transactions:

Prev: 9/30/2020: XtalPi venture capital transaction
Next: 9/30/2020: PayCargo venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary